The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion
Open accessAbstract
The neuropeptide calcitonin gene-related peptide (CGRP) from the trigeminal ganglion has been established as a key player in the pathogenesis of migraine. In this study, we provide evidence that the responsiveness of neuronal CGRP receptors is strongly enhanced in vitro and in vivo by expression of human receptor activity-modifying protein-1 (hRAMP1), an obligatory subunit of the CGRP receptor. We first demonstrated that activation of CGRP receptors on cultured trigeminal ganglion neurons increased endogenous CGRP mRNA levels and promoter activity. The promoter activation was cAMP dependent and blocked by the antagonist BIBN4096BS [1-piperidinecarboxamide,N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl)], a new antimigraine drug. Gene transfer using an adenoviral hRAMP1 expression vector increased the maximal production of cAMP by 1.8 ± 0.2-fold and decreased the EC 50 to 2.3 ± 0.8 n m from 9.0 ± 5.9 n m and 15.6 ± 5.2 n m in uninfected and control-infected cultures, respectively. To establish whether RAMP1 is limiting in vivo as indicated from the culture studies, a transgenic mouse expressing hRAMP1 in the nervous system was generated. After CGRP injection into the whiskerpad, the hRAMP1 transgenic mice displayed 2.2 ± 0.2-fold greater plasma extravasation, which is a measure of neurogenic inflammation. These results demonstrate that RAMP1 is functionally rate limiting for CGRP receptor activity in the trigeminal ganglion, which raises the possibility that elevated RAMP1 might sensitize some individuals to CGRP actions in migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581 · cited 2×
“The hRAMP1 and SV40 polyA fragment was then cloned into HindIII and NotI sites of the pbsCX1-LEL expression vector provided by G. Owens (University of Virginia, Charlottesville, VA) (Okabe et al., 1997; Dikalova et al., 2005) to generate pbsCX1-LEL-hRAMP1.”
MethodRAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 3×
“RAMP1 is known to exist as monomer ( 15 kDa) and dimer ( 30 kDa), even under denaturing conditions (McLatchie et al., 1998). dependent activation of mitogen-activated protein (MAP) kinases (C. S. Winborn, unpublished data).”
BackgroundInfluentialPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 6×
“A second, less prevalent CGRP receptor has been suggested, although its molecular identity remains unclear (Poyner et al., 2002).”
BackgroundResultInfluentialVascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765 · cited 4×
“Both substance P and CGRP cause redness and swelling near the injection site in the skin (Brain and Grant, 2004).”
BackgroundResultInfluentialChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438 · cited 2×
“The hRAMP1 and SV40 polyA fragment was then cloned into HindIII and NotI sites of the pbsCX1-LEL expression vector provided by G. Owens (University of Virginia, Charlottesville, VA) (Okabe et al., 1997; Dikalova et al., 2005) to generate pbsCX1-LEL-hRAMP1.”
MethodHay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
Research works printed but not linked: 51
- 10.1023/A:1006962221332 · DOI
- 10.1111/j.1471-4159.2004.02833.x · DOI
- 10.1242/jcs.02598 · DOI · Paper page
- 10.1210/en.140.6.2883 · doi:10.1210/en.140.6.2883
- 10.1124/mol.59.6.1533 · DOI
- 10.1074/jbc.C200629200 · DOI · Paper page
- 10.1002/cne.20669 · DOI
- 10.1016/j.bbrc.2004.10.205 · DOI
- 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
- 10.1002/dvg.20226 · DOI · Paper page
- 10.1056/NEJMp048016 · doi:10.1056/nejmp048016
- Durham, 1999, Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug, J Neurosci, 19, 3423, 10.1523/JNEUROSCI.19-09-03423.1999 · DOI · Paper page
- Durham, 2003, Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons, J Neurosci, 23, 807, 10.1523/JNEUROSCI.23-03-00807.2003 · DOI
- 10.1016/j.brainres.2003.11.005 · DOI
- 10.1016/S0304-3940(97)00456-4 · DOI
- 10.1016/S0014-2999(01)01532-1 · DOI
- 10.1074/jbc.M005604200 · DOI · Paper page
- 10.1523/JNEUROSCI.0647-06.2006 · DOI · Paper page
- 10.1016/S0306-4522(03)00163-5 · DOI
- 10.1523/JNEUROSCI.0869-05.2005 · DOI
- 10.1006/bbrc.2000.2552 · DOI
- 10.1046/j.1468-2982.1995.1505384.x · doi:10.1046/j.1468-2982.1995.1505384.x · Paper page
- 10.1074/jbc.270.35.20599 · DOI · Paper page
- 10.1038/nrd1822 · DOI
- 10.1517/14728214.11.3.419 · DOI
- 10.1002/ana.410280213 · DOI · Paper page
- 10.1056/NEJMra010917 · DOI · Paper page
- 10.1016/S0896-6273(01)00374-9 · DOI · Paper page
- 10.1111/j.1749-6632.1998.tb11158.x · DOI
- 10.1124/mol.106.027953 · DOI
- 10.1016/S0006-8993(98)00269-8 · doi:10.1016/s0006-8993(98)00269-8
- 10.1016/j.pain.2003.09.008 · DOI · Paper page
- 10.1046/j.1468-2982.2002.00310.x · DOI · Paper page
- 10.1002/ana.20619 · DOI · Paper page
- 10.1016/S0306-4522(03)00159-3 · DOI
- 10.1016/S0006-8993(01)02888-8 · DOI
- Moreno, 1999, Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture, J Cereb Blood Flow Metab, 19, 1270, 10.1097/00004647-199911000-00012 · DOI
- 10.1016/S0028-3908(02)00008-4 · DOI
- 10.1210/en.140.6.2924 · doi:10.1210/en.140.6.2924 · Paper page
- 10.1016/j.pain.2005.04.002 · DOI
- 10.1056/NEJMoa030505 · DOI · Paper page
- Oliver, 2002, Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature, J Cereb Blood Flow Metab, 22, 620, 10.1097/00004647-200205000-00014 · DOI
- 10.1016/S0306-4522(01)00547-4 · DOI
- 10.1038/sj.bjp.0705807 · DOI · Paper page
- 10.1152/jn.01293.2005 · DOI · Paper page
- 10.1161/01.RES.0000200737.63865.58 · DOI
- 10.1016/j.brainresrev.2004.11.006 · DOI · Paper page
- 10.1038/12703 · DOI · Paper page
- 10.1016/S0304-3959(00)00439-5 · DOI
- 10.1159/000087190 · DOI
- 10.1210/en.2005-0918 · DOI
Cited by
Pietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
A Phase‐by‐Phase Review of Migraine Pathophysiology
Dodick, D. W. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13300 · Cited by 505
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Russo, A. F. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124701 · Cited by 389
Self-citationCGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Self-citation
Metadata
- Authors
- Zhang, Z., Winborn, C. S., Marquez de Prado, B., & Russo, A. F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-07
- Volume
- 27
- Issue
- 10
- Pages
- 2693-2703
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2038864055
- Cited by
- 234
- References
- 7
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.